Zebularine inhibits tumorigenesis and stemness of colorectal cancer via p53-dependent endoplasmic reticulum stress

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Yang, Pei Ming ^a,b   Lin, Yi Ting ^a   Shun, Chia Tung ^c   Lin, Shan Hu ^a   Wei, Tzu Tang ^a   Chuang, Shu Hui ^a   Wu, Ming Shiang ^c   Chen, Ching Chow ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTIDINE; MDM2 PROTEIN, HUMAN; PROTEIN MDM2; PROTEIN P53; PYRIMIDIN-2-ONE BETA-RIBOFURANOSIDE; RIBOSOMAL PROTEIN S7; RIBOSOME PROTEIN;

ANALOGS AND DERIVATIVES; ANIMAL; AUTOPHAGY; BAGG ALBINO MOUSE; C57BL MOUSE; CARCINOGENESIS; CELL DEATH; CELL LINE; COLORECTAL NEOPLASMS; DNA DAMAGE; DNA METHYLATION; DOWN REGULATION; DRUG EFFECTS; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; HCT116 CELL LINE; HELA CELL LINE; HUMAN; MALE; MCF 7 CELL LINE; METABOLISM; MOUSE; NUDE MOUSE; SIGNAL TRANSDUCTION; TUMOR CELL LINE; UNFOLDED PROTEIN RESPONSE; UPREGULATION;

ANIMALS; AUTOPHAGY; CARCINOGENESIS; CELL DEATH; CELL LINE; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; CYTIDINE; DNA DAMAGE; DNA METHYLATION; DOWN-REGULATION; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; HCT116 CELLS; HELA CELLS; HUMANS; MALE; MCF-7 CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; PROTO-ONCOGENE PROTEINS C-MDM2; RIBOSOMAL PROTEINS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; UNFOLDED PROTEIN RESPONSE; UP-REGULATION;

EID: 84889566398     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03219     Document Type: Article

References (52)

1. Copeland, R. A.,Olhava, E. J.&Scott, M. P. Targeting epigenetic enzymes for drug discovery. Curr. Opin. Chem. Biol. 14, 505-510 (2010)
2. Bender, C. M. et al. Roles of cell division and gene transcription in the methylation of CpG islands. Mol. Cell. Biol. 19, 6690-6698 (1999) (Pubitemid 29441853)
3. Karpf, A. R., Moore, B. C., Ririe, T. O. & Jones, D. A. Activation of the p53 DNA damage response pathway after inhibition of DNA methyltransferase by 5-aza-2'-deoxycytidine. Mol. Pharmacol. 59, 751-757 (2001) (Pubitemid 32274003)
4. Laliberte, J., Marquez, V. E. & Momparler, R. L. Potent inhibitors for the deamination of cytosine arabinoside and 5-aza-2'-deoxycytidine by human cytidine deaminase. Cancer Chemother. Pharmacol. 30, 7-11 (1992)
5. Chabner, B. A., Drake, J. C. & Johns, D. G. Deamination of 5-azacytidine by a human leukemia cell cytidine deaminase. Biochem. Pharmacol. 22, 2763-2765 (1973)
6. Lemaire, M.,Momparler, L. F., Raynal, N. J., Bernstein, M. L. &Momparler, R. L. Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine. Cancer Chemother. Pharmacol. 63, 411-416 (2009)
7. Cheng, J. C. et al. Inhibition of DNA methylation and reactivation of silenced genes by zebularine. J. Natl. Cancer Inst. 95, 399-409 (2003) (Pubitemid 36395260)
8. Cheng, J. C. et al. Preferential response of cancer cells to zebularine. Cancer Cell 6, 151-158 (2004) (Pubitemid 39485687)
9. Ben-Kasus, T., Ben-Zvi, Z., Marquez, V. E., Kelley, J. A. & Agbaria, R. Metabolic activation of zebularine, a novel DNA methylation inhibitor, in human bladder carcinoma cells. Biochem. Pharmacol. 70, 121-133 (2005) (Pubitemid 40797876)
10. Li, L. H., Olin, E. J., Buskirk, H. H. & Reineke, L. M. Cytotoxicity and mode of action of 5-azacytidine on L1210 leukemia. Cancer Res. 30, 2760-2769 (1970)
11. Cihak, A. Biological effects of 5-azacytidine in eukaryotes. Oncology 30, 405-422 (1974)
12. Warner, J. R. The economics of ribosome biosynthesis in yeast. Trends Biochem. Sci. 24, 437-440 (1999) (Pubitemid 29528205)
13. Hollenbach, P. W. et al. A comparison of azacitidine and decitabine activities in acute myeloid leukemia cell lines. PLoS ONE 5, e9001 (2010)
14. Aimiuwu, J. et al. RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia. Blood 119, 5229-5238 (2012)
15. Vousden, K. H. & Lu, X. Live or let die: The cell's response to p53. Nat. Rev. Cancer 2, 594-604 (2002) (Pubitemid 37328926)
16. Zhang, Y.&Lu, H. Signaling to p53: ribosomal proteins find their way. Cancer Cell 16, 369-377 (2009)
17. Shore, G. C., Papa, F. R. & Oakes, S. A. Signaling cell death from the endoplasmic reticulum stress response. Curr. Opin. Cell Biol. 23, 143-149 (2011)
18. Tabas, I. & Ron, D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat. Cell Biol. 13, 184-190 (2011)
19. Kim, R., Emi, M., Tanabe, K. & Murakami, S. Role of the unfolded protein response in cell death. Apoptosis 11, 5-13 (2006) (Pubitemid 43151639)
20. Stein, A., Atanackovic, D. & Bokemeyer, C. Current standards and new trends in the primary treatment of colorectal cancer. Eur. J. Cancer 47 Suppl 3, S312-314 (2011)
21. Hannan, K. M., Hannan, R. D. & Rothblum, L. I. Transcription by RNA polymerase I. Front. Biosci. 3, d376-398 (1998)
22. Chen, D. et al. Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: Binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene 26, 5029-5037 (2007) (Pubitemid 47206956)
23. Zhu, Y. et al. Ribosomal protein S7 is both a regulator and a substrate of MDM2. Mol. Cell 35, 316-326 (2009)
24. Hoyer-Hansen, M. & Jaattela, M. Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium. Cell Death Differ. 14, 1576-1582 (2007) (Pubitemid 47278843)
25. Mathew, R., Karantza-Wadsworth, V. & White, E. Role of autophagy in cancer. Nat. Rev. Cancer 7, 961-967 (2007) (Pubitemid 350165856)
26. Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8, 445-544 (2012)
27. Mathew, R. et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell 137, 1062-1075 (2009)
28. O'Brien, C. A., Pollett, A., Gallinger, S. & Dick, J. E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106-110 (2007) (Pubitemid 46067310)
29. Ricci-Vitiani, L. et al. Identification and expansion of human colon-cancerinitiating cells. Nature 445, 111-115 (2007) (Pubitemid 46067311)
30. Dalerba, P. et al. Phenotypic characterization of human colorectal cancer stem cells. Proc. Natl. Acad. Sci. U. S. A. 104, 10158-10163 (2007) (Pubitemid 47175279)
31. Todaro, M., Francipane, M. G.,Medema, J. P. & Stassi, G. Colon cancer stem cells: Promise of targeted therapy. Gastroenterology 138, 2151-2162 (2010)
32. Huang, E. H. et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res. 69, 3382-3389 (2009)
33. Tanaka, T. et al. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci. 94, 965-973 (2003) (Pubitemid 37508979)
34. Jemal, A. et al. Cancer statistics, 2008. CA. Cancer J. Clin. 58, 71-96 (2008) (Pubitemid 351521864)
35. Hodge, D. R. et al. Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation. Cancer Res. 65, 4673-4682 (2005) (Pubitemid 40740803)
36. Burger, K. et al. Chemotherapeutic drugs inhibit ribosome biogenesis at various levels. J. Biol. Chem. 285, 12416-12425 (2010)
37. Kessis, T. D. et al. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc. Natl. Acad. Sci. U. S. A. 90, 3988-3992 (1993) (Pubitemid 23134151)
38. Yang, P. M. et al. Inhibition of autophagy enhances anticancer effects of atorvastatin in digestive malignancies. Cancer Res. 70, 7699-7709 (2010)
39. Yoon, C.H., Lee, E. S., Lim,D. S. &Bae, Y. S. PKR, a p53 target gene, plays a crucial role in the tumor-suppressor function of p53. Proc. Natl. Acad. Sci. U. S. A. 106, 7852-7857 (2009)
40. McCullough, K. D., Martindale, J. L., Klotz, L. O., Aw, T. Y. & Holbrook, N. J. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol. Cell. Biol. 21, 1249-1259 (2001) (Pubitemid 32114973)
41. Puthalakath, H. et al. ER stress triggers apoptosis by activating BH3-only protein Bim. Cell 129, 1337-1349 (2007) (Pubitemid 46962086)
42. Ohoka, N., Yoshii, S., Hattori, T., Onozaki, K. & Hayashi, H. TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death. EMBO J. 24, 1243-1255 (2005) (Pubitemid 40516607)
43. Yamaguchi, H.&Wang, H. G. CHOP is involved in endoplasmic reticulum stressinduced apoptosis by enhancing DR5 expression in human carcinoma cells. J. Biol. Chem. 279, 45495-45502 (2004) (Pubitemid 39491535)
44. Marciniak, S. J. et al. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev. 18, 3066-3077 (2004) (Pubitemid 39658175)
45. Mungrue, I. N., Pagnon, J., Kohannim, O., Gargalovic, P. S. & Lusis, A. J. CHAC1/MGC4504 is a novel proapoptotic component of the unfolded protein response, downstream of the ATF4-ATF3-CHOP cascade. J. Immunol. 182, 466-476 (2009)
46. Southwood, C. M., Garbern, J., Jiang, W. & Gow, A. The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron 36, 585-596 (2002) (Pubitemid 35350849)
47. Moscat, J., Diaz-Meco, M. T. & Wooten, M. W. Signal integration and diversification through the p62 scaffold protein. Trends Biochem. Sci. 32, 95-100 (2007) (Pubitemid 46199192)
48. Shvets, E., Fass, E., Scherz-Shouval, R. & Elazar, Z. The N-terminus and Phe52 residue of LC3 recruit p62/SQSTM1 into autophagosomes. J. Cell Sci. 121, 2685-2695 (2008)
49. Wu, M. J. et al. Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling. Mol. Cancer 9, 283 (2010)
50. Galavotti, S. et al. The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells. Oncogene 32, 699-712 (2013)
51. Yoo, C. B., Cheng, J. C. & Jones, P. A. Zebularine: A new drug for epigenetic therapy. Biochem. Soc. Trans. 32, 910-912 (2004) (Pubitemid 39655501)
52. Liu, Y. L. et al. Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma. Autophagy 6, 1057-1065 (2010)